Agilent Technologies, Inc. (A) News
Filter A News Items
A News Results
|Loading, please wait...|
A News Highlights
- For A, its 30 day story count is now at 38.
- Over the past 26 days, the trend for A's stories per day has been choppy and unclear. It has oscillated between 1 and 8.
- The most mentioned tickers in articles about A are ENTA, JD and NIO.
Latest A News From Around the Web
Below are the latest news stories about Agilent Technologies Inc that investors may wish to consider to help them evaluate A as an investment opportunity.
In this article, we will take a look at the 10 best stocks under $200 according to Edgar Wachenheim’s Greenhaven Associates. You can skip our detailed analysis of Edgar Wachenheim’s history, investment philosophy, and hedge fund performance, and go directly to the 5 Best Stocks Under $200 According to Edgar Wachenheim’s Greenhaven Associates. Greenhaven Associates […]
These penny stocks remain positioned to run upwards in the near term.
The following slide deck was published by Agilent Technologies, Inc. in conjunction with their 2021 Q4 earnings call....
Agilent Technologies, Inc. (A) Q4 2021 Earnings Conference Call November 22, 2021 4:30 PM ET Company Participants Parmeet Ahuja - Vice President of Investor Relations Mike McMullen - President and Chief Executive Officer Bob McMahon - Senior Vice President and Chief Financial Officer Jacob Thaysen - President, Life Sciences and...
Analysts Offer Insights on Healthcare Companies: Agilent (A), Enanta Pharmaceuticals (ENTA) and Arrowhead Pharmaceuticals (ARWR)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Agilent (A – Research Report), Enanta Pharmaceuticals (ENTA – Research Report) and Arrowhead Pharmaceuticals (ARWR – Research Report). Agilent (A) Leerink Partners analyst Puneet Souda maintained a Buy rating on Agilent today and set a price target of $175.00. The company's shares closed last Monday at $162.78. According to TipRanks.
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Seagen (SGEN – Research Report), Agilent (A – Research Report) and Enanta Pharmaceuticals (ENTA – Research Report) with bullish sentiments. Seagen (SGEN) H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Seagen today and set a price target of $200.00. The company's shares closed last Monday at $176.12. According to TipRanks.
SANTA CLARA, Calif., November 23, 2021--Agilent to present at Evercore ISI Virtual Healthcare Conference.
Agilent Technologies' (A) fourth-quarter fiscal 2021 results reflect a solid end-market momentum and strong growth across Americas and China.
In this article, we will take a look at the 10 stocks in the limelight after quarterly reports. You can skip our detailed analysis of these companies, and go directly to the 5 Stocks in The Limelight After Quarterly Reports. U.S. stocks from consumer cyclical, healthcare, communication services, and technology sectors recently released their quarterly […]
A earnings call for the period ending October 31, 2021.